If symptoms suggest a new endocrine problem, baseline testing is reasonable before starting therapy, with a follow-up check at three months for the standard panels: HbA1c, fasting glucose, TSH, and free T4 if on thyroid therapy, morning cortisol only when clinically indicated, and sex hormones if symptoms arise
By stimulating insulin secretion, suppressing glucagon release, and slowing gastric emptying, semaglutide helps lower blood sugar levels, which can positively impact cardiovascular health
Firming 2% Copper Peptide serum to boost collagen, smooth fine lines, and rejuvenate aging skin for a youthful, resilient, radiant complexion
Call the DBHIDS helpline at 888-545-2600 or check our resources section for more information
Two areas of emerging research deserve particular attention: Non-HIV metabolic populations: Several investigators have studied tesamorelin in adults with abdominal obesity and metabolic syndrome, with consistent signals toward VAT reduction and improvements in liver fat in patients with non-alcoholic fatty liver disease